BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Marshall GP 2nd, Cserny J, Perry DJ, Yeh WI, Seay HR, Elsayed AG, Posgai AL, Brusko TM. Clinical Applications of Regulatory T cells in Adoptive Cell Therapies. Cell Gene Ther Insights 2018;4:405-29. [PMID: 34984106 DOI: 10.18609/cgti.2018.042] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Marshall GP, Cserny J, Wang CW, Looney B, Posgai AL, Bacher R, Keselowsky B, Brusko TM. Biomaterials-based nanoparticles conjugated to regulatory T cells provide a modular system for localized delivery of pharmacotherapeutic agents. J Biomed Mater Res A 2023;111:185-97. [PMID: 36082558 DOI: 10.1002/jbm.a.37442] [Reference Citation Analysis]
2 Brown ME, Peters LD, Hanbali SR, Arnoletti JM, Sachs LK, Nguyen KQ, Carpenter EB, Seay HR, Fuhrman CA, Posgai AL, Shapiro MR, Brusko TM. Human CD4(+)CD25(+)CD226(-) Tregs Demonstrate Increased Purity, Lineage Stability, and Suppressive Capacity Versus CD4(+)CD25(+)CD127(lo/-) Tregs for Adoptive Cell Therapy. Front Immunol 2022;13:873560. [PMID: 35693814 DOI: 10.3389/fimmu.2022.873560] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Shapiro MR, Peters LD, Brown ME, Cabello-kindelan C, Posgai AL, Bayer AL, Brusko TM. Insulin-like Growth Factor-1 Synergizes with IL-2 to Induce Homeostatic Proliferation of Regulatory T cells.. [DOI: 10.1101/2022.05.12.491665] [Reference Citation Analysis]
4 Nambam B, Haller MJ, Winter WE, Schatz D. Autoimmune Polyglandular Syndromes. Sperling Pediatric Endocrinology 2021. [DOI: 10.1016/b978-0-323-62520-3.00022-1] [Reference Citation Analysis]